Allium Financial Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Allium Financial Advisors, LLC
- $110 Billion
- Q1 2025
A detailed history of Allium Financial Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Allium Financial Advisors, LLC holds 404 shares of REGN stock, worth $243,846. This represents 0.23% of its overall portfolio holdings.
Number of Shares
404Holding current value
$243,846% of portfolio
0.23%Shares
1 transactions
Others Institutions Holding REGN
# of Institutions
1,481Shares Held
87.4MCall Options Held
1.53MPut Options Held
1.43M-
Vanguard Group Inc Valley Forge, PA9.29MShares$5.61 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.1 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.26 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.92 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$2.86 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $64.7B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...